NovaBay Pharmaceuticals, Inc. Retained Earnings

Retained Earnings of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Retained Earnings growth rates and interactive chart.


Highlights and Quick Summary

  • Retained Earnings for the quarter ending June 30, 2022 was $-144 Million (a 1.52% increase compared to previous quarter)
  • Year-over-year quarterly Retained Earnings increased by 1.71%
  • Annual Retained Earnings for 2021 was $-142 Million (a 4.28% increase from previous year)
  • Annual Retained Earnings for 2020 was $-136 Million (a 8.83% increase from previous year)
  • Annual Retained Earnings for 2019 was $-125 Million (a 8.73% increase from previous year)
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Retained Earnings of NovaBay Pharmaceuticals, Inc.

Most recent Retained Earningsof NBY including historical data for past 10 years.

Interactive Chart of Retained Earnings of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Retained Earnings for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-144.15 $-142.0
2021 $-141.89 $-141.73 $-139.44 $-137.58 $-141.89
2020 $-136.06 $-134.31 $-131.09 $-126.61 $-136.06
2019 $-125.02 $-122.34 $-122.06 $-119.53 $-125.02
2018 $-114.98 $-113.71 $-112.18 $-110.59 $-114.98
2017 $-111.07 $-111.87 $-109.42 $-107.68 $-111.07
2016 $-103.67 $-102.02 $-98.29 $-95.6 $-103.67
2015 $-90.52 $-86.32 $-81.07 $-90.52
2014 $-71.55 $-67.08 $-62.86 $-59.92 $-71.55
2013 $-56.35 $-52.22 $-48.37 $-44.32 $-56.35
2012 $-40.31 $-37.96 $-38.04 $-35.82 $-40.31
2011 $-33.28 $-29.66 $-33.28

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology